1Schultz HD, Li YL, Ding Y. Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension, 2007,50:6-13.
3Humphrey JD. Mechanisms of arterial remodeling in hypertension : coupled roles of wall shear and intramural stress. Hypertension, 2008, 52 : 195-200.
4Johnson R J, Feig DI, Nakagawa T, et al. Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens, 2008, 26:381-391.
5Hall JE. The kidney, hypertension, and obesity. Hypertension, 2003,41(3 Pt 2): 625-633.
6Mottl AK, Shoham DA, North KE. Angiotensin Ⅱ type 1 reeeptor polymorphisms and susceptibility to hypertension : a HuGE review. Genet Meal, 2008, 10: 560-574.
7Sookoian S, Gianotti TF, Gonzalez CD, et al. Association of the C-344T aldosterone synthase gene variant with essential hypertension : a meta-analysis. J Hypertens, 2007, 25 : 5-13.
9Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension. A scientific statement from the American Heart Association. Hypertension, 2006, 47: 296-308.
10O'Brien E, Barton J, Nussberger J, et al. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. Hypertension, 2007, 49 : 276- 284.
5Engstrom CP,Person LO,Larsson S,et al.Reliability and validity of a swedish version of the St Georgr's respiratory questionnaire[J].European Respiratory Journal,1998,11(1):61-66.
